Imbruvica (ibrutinib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Imbruvica (ibrutinib), covering 2024-01-26 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants